After netting $200M, Synthego to break ground on its manufacturing facility
California-based biotech Synthego has been mainly focused on developing CRISPR-based tools to help researchers in academia and biotech, but its latest move now is turning its attention more towards manufacturing.
The company has broken ground on a 20,000-square-foot manufacturing facility in the San Francisco Bay Area, expanding its GMP capacity by 30 times, Synthego said in an email to Endpoints News. The facility is also going to manufacture materials for translational and clinical research development for cell and gene therapies as well.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.